Evaluation of molecular diagnostic test for detection of adult pulmonary tuberculosis: A generic protocol

Abstract Background & objectives: Tuberculosis (TB) continues to be the second most-leading cause of death due to a single infectious agent as of 2022 after COVID-19. Many affordable new molecular diagnostic tools are being developed for early and more accurate diagnosis, especially for low-reso...

Full description

Saved in:
Bibliographic Details
Published inIndian Journal of Medical Research Vol. 159; no. 2; pp. 246 - 253
Main Authors Jayaprakasam, Madhumathi, Pandey, Ravindra Mohan, Choudhary, Hansraj, Shanmugam, Sivakumar, Sivaramakrishnan, Gomathi N., Gupta, Nivedita
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer - Medknow 01.02.2024
Scientific Scholar
Edition2
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background & objectives: Tuberculosis (TB) continues to be the second most-leading cause of death due to a single infectious agent as of 2022 after COVID-19. Many affordable new molecular diagnostic tools are being developed for early and more accurate diagnosis, especially for low-resource settings in low- and middle-income countries. In this context, there is a need to develop a standardized protocol for validation of new diagnostic tools. Here, we describe a generic protocol for multi-centric clinical evaluation of molecular diagnostic tests for adult pulmonary TB. Methods: This protocol describes a cross-sectional study in TB reference laboratories in India. Adults (>18 yr) visitng the chest clinics or outpatient departments with symptoms of TB need to be enrolled consecutively till the required sample size of 150 culture positives and 470 culture negatives are met. Mycobacterium tuberculosis (Mtb) culture (mycobacteria growth indicator tube liquid culture) to be used under this protocol as the gold standard and Xpert MTB/RIF molecular test will be used as the comparator. The sputum samples will be tested by smear microscopy, Mtb culture, Xpert MTB/RIF and index molecular test as per the proposed algorithm. The specificity sensitivity, and positive/ negative predictive values are to be calculated for the index test with reference to the gold standard. Discussion: TB diagnosis poses many challenges as it differs with type of disease, age group, clinical settings and type of diagnostic tests/kits used. Globally, different protocols are used by several investigators. This protocol provides standard methods for the validation of molecular tests for diagnosis of adult pulmonary TB, which can be adopted by investigators.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0971-5916
0975-9174
DOI:10.4103/ijmr.ijmr_2316_23